Brief Reports Open Access
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Apr 15, 2000; 6(2): 268-270
Published online Apr 15, 2000. doi: 10.3748/wjg.v6.i2.268
The prevalence of transfusion transmitted virus infection in blood donors
Cheng Hui Huang, Ru Guang Chen, Department of Blood Transfusion Research, Shenzhen Baoan Blood Center, Shenzhen 518101, Guangdong Province, China;
Yu Sen Zhou, Hai Tao Wang Department of Hepatitis Virus, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China;
Chun Ying Xie, Department of Molecular Biology, Shenzhen Bao'an People′s Hospital, Shenzhen 518101, Guangdong Province, China;
Cheng Hui Huang, graduated from Capital University of Medical Sciences as postgraduate in 1997, now assistant researcher, majoring hepatitis, having 5 papers published.
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Cheng Hui Huang, Department of Blood Transfusion Research, Shenzhen Baoan Blood Center, Shenzhen 518101, Guangdong Province, China. Email: szbaxzch@public.szptt.net.cn
Telephone: 0086-755-7751196, Fax. 0086-755-7752009
Received: May 23, 1999
Revised: August 26, 1999
Accepted: September 2, 1999
Published online: April 15, 2000

Abstract
Key Words: transfusion transmitted virus infection; blood donors; liver diseases; hemodialysis



INTRODUCTION

A newly discovered DNA virus, transfusion transmitted virus (TTV), was reported as a cause of post-transfusion hepatitis of unknown etiology in Japan[1]. In order to investigate TTV prevalence in southern China, a study was carried out among blood donors, patients with liver diseases and hemodialysis to deter mine the epidemiological charateristics.

MATERIALS AND METHODS
Samples

Sera or plasma samples (471) were obtained from volunteer blood donors from Shen zhen Baoan Blood Center and commercial blood donors from Dongguan Blood Center. Sera samples (117) from patients with liver disease and hemodialysis were collected from Shenzhen Baoan People′s Hospital. All the sera or plasma samples were stored at -70 °C for detection.

Reagents

Hepatitis B surface antigen (HBsAg), antibodies to hepatitis C virus (HCV), antibodies to human immuno-deficiency virus (HIV) EIA kits were purchased from Abbott Laboratories (Abbott Park, IL). Syphlis TPHA kits were purchased from Randox Laboratories Ltd. IgM antibodies to hepatitis A virus, antibodies to hepatitis E virus ELISA reagent kits, HBV, HCV and HGV polymerase chain reaction (PCR) reagent kits were purchased from the Institute of Hepatology of Beijing Medical University.

Laboratory tests

The serum specimens from blood donors were tested for ananine aminotransferase (ALT) levels (less than or equal to 40 IU/L), HBsAg, antibodies to HCV, antibodies to HIV and syphlis TPHA. The patients with liver disease were further detected for markers of HAV, HBV, HCV, HEV and HGV infection.

Detection of TTV DNA by nPCR[2]

Nucleic acid was extracted from 100 μL serum with AcuPure DNA/RNA extraction kit (Biotronics Tech. Corp.) following the -manufacturer′s-recommended protocol. According to the sequence of TTV TA278 strain (GenBank accesion number AB008394) two pair nested primers were designed for nested polymerase chain reaction (nPCR). The first-round PCR was performed with P1 (sense: 5′-CCAGGAGCATATACAGAC-3′) and P2 (anti-sense: 5′-TACTTCTTGCTGGTGAAAT-3′) for 30 cycles (pre-denaturing for 180 s at 94 °C, denaturing for 40 s at 94 °C, annealing for 40s at 55 °C, extension for 40 s at 72 °C). The second-round PCR was carried out with P3 (sense: 5′-CAGACAGAGGAGAAGGCAAC-3′) and P4 (anti-sense: 5′-ACAGGCACATTACTACTACC-3′) for 30 cycles for amplification of 309 bp product. The second-round PCR was done in the same manner as the first-round. Amplified products were separated in 2% agorase gel electrophoresis, stained with ethidium bromide and observed under ultraviolet light.

Cloning and sequencing of TTV genome

The purified products of PCR were directly ligated into pBluescript-T vector (Invitrogen Company), and with recombinant plasmid obtained by introduction into E. coli XL1-blue, sequences were determined for both strands by the sanger dideoxy chain termination methods, and with sequencer (model ABI373; Applied Biosystems, Foster City, CA).

Data analysis

The sequences of TTV genome were analyzed by the computer program CLUSTALW version 1.1 and the computer program GOLDKEY version 1.1. Statistical analysis was made using statistical program SYSTAT version 3.0.

RESULTS
The results of TTV DNA determined by nPCR in blood donors

Four hundred and seventy-one sera samples from volunteer blood donors and commercial blood donors were all negative for markers of HBsAg, anti-HCV, anti-HIV and TPHA. Fifty-eight of 471 sera samples had an elavated ALT (mean 89 IU/L ± 45 IU/L) and with no markers of hepatitis A-G virus infection. The results of TTV DNA detected by nPCR from blood donors are shown in Figure 1 and Table 1. Among volunteer blood donors with normal transaminase levels, 30 (14.7%) of 204 were positive for TTV DNA. In contrast, 48 (23.0%) of 209 commercial blood donors with normal transaminase levels, and 18 (31.0%) of 58 blood donors with elevated transaminase levels were positive for TTV DNA. The prevalence of TTV in blood donors with elevated transaminase levels was significantly higher than in volunteer blood donors (P < 0.01) and commercial blood donors with normal transaminase levels (P < 0.05). There was no significant difference between the commercial blood donors with normal transaminase levels and the blood donors with elevated transaminase levels.

Table 1 The results of TTV DNA detected by PCR in sera of blood donors.
Blood donorsNo. of sampleTTV DNA (+)
n%
Commercial blood donors with normal ALT levels2094823.1
Volunteer blood donors with normal ALT levels2043014.4
Blood donors with elevated ALT levels581831.0
Figure 1
Figure 1 Agorase electrophoresis of TTV DNA PCR products. M: marker; 1: negative control; 2-8: positive
The results of TTV DNA detected by PCR in patients with liver diseases and hemodialysis

One hundred and five serum specimens from patients with liver diseases were detected for TTV DNA by nPCR. The results are shown in Table 2. Among 36 non-A to E hepatitis patients, 15 (41.6%) were PCR positive for TTV DNA. One of 13 (7.7%) patients with hepatitis A virus infection was positive for TTV DNA, 3 (23.1%) of 13 patients with hepatitis B virus infection and 8 (18.6%) of 43 patients with hepatitis C virus infection were positive for TTV DNA. The prevalence of TTV in non-A to E hepatitis patients was significantly higher than in patients with HAV or HBV and HCV infection. Among 12 cases of hemodialysis, 5 (41.7%) were PCR positive for TTV DNA.

Table 2 The results of TTV DNA detected by PCR in sera of the patients with liver diseases and hemodialysis.
PatientsCases testedTTV DNA (+)
n%
Non-A to E hepatitis patients361541.6
Hepatitis A patients1317.7
Hepatitis B patients13323.1
Hepatitis C patients43818.6
Hemodialysis12541.7
The sequencing results of TTV partial genome from blood donors

The anticipated DNA fragments amplified by PCR from 5 blood donors were cloned and sequenced for both strands. The similarity of nucleotide sequences of partial gene within TTV ORF1 region among 5 isolates from blood donors ranged from 98.4% to 99.4%. There was a 97% nucleotide identity among AB008394 (from Japan), TTVCHIN1 (from northern China) and our 5 isolates from blood donors (Figure 2 and Table 3).

Figure 2
Figure 2 Comparison of isolates from blood dono rs (cases 1-5) with corresponding sequences from Japan (AB008394) and China (TTVCHN1).
Table 3 Homologies of nucleotide sequences among isolates from blood donors of Japan and China (%).
TTV isolatesAB008394TTVCHN1Case 1Case 2Case 3Case 4
TTVCHN198.7
Case 198.499.7
Case 297.799.199.4
Case 397.799.199.498.7
Case 498.499.799.498.798.7
Case 598.199.499.198.498.499.1
DISCUSSION

Transfusion transmitted virus (TTV) is a newly discovered virus associated with the patients with post-transfusion hepatitis of unknown etiology in Japan. The preliminary studies showed that TTV was a single-stranded DNA virus, and the nucleotide sequence of TTV DNA genome was composed of approximately 3.7 kp, including two open reading frame (ORF) which encodes for 770 amino acids (aa) and 202 aa, respectively[3]. TTV resembles to some known animal single-stranded DNA viruses, such as chicken anemia virus and human parvovirus B19. Some studies reported that TTV was associated with post-transfusion and acute and chronic hepatitis of unknown etiology. So far, no reliable serologic assay for antibodies against TTV infection has been developed. Thus, PCR was utilized to determine the prevalence of TTV infection in different populations.

Based on the conserved nucleotide sequence of TTV ORF1 gene, a nested-PCR for TTV DNA was established in our study. The specificity of amplified targets was documented by sequencing the PCR products selected from 5 blood donors positive for TTV DNA (Figure 2). The epidemiological investigation indicated that there was a high prevalence of TTV infection in volunteer blood donors and commercial blood donors. Simmonds et al[4] reported that TTV viraemia was detected in 19 (1.9%) of 1000 non-remunerated regular blood donors from Scotland, 10% from England.

Fourty-four to 56% factor VIII and IX had a TTV contamination. In this study, nearly 15%-31% of blood donors from southern China were TTV DNA positive. Hemodialysis patients were considered at “high-risk” for exposure to parenterally transmitted viruses, such as HBV and HCV. TTV DNA positive rate was 41.7% in our data. The results suggested that TTV can be parenterally transmitted to recipients of blood or blood products.

Fifty-eight blood donors with elevated serum ALT levels were tested without markers of hepatitis A to G viruses. The positive rate of TTV DNA was 31%, which was higher than in volunteer blood donors with normal ALT levels (14%-7%). The results indicated that some blood donors with abnormal ALT was associated with TTV infection.

The pathogenicity of TTV is unclear. The clinical and epidemiological studies showed that the TTV infection was found among patients with fulminant hepatitis, acute and chronic liver disease of unknown etiology[3,5]. In our study, the prevalence of TTV was higher in patients with non-A to G hepatitis (41.6%) than in patients with hepatitis A to C virus infection, indicating that TTV may be responsible for some cases of non-A to E hepatitis. Recent studies demonstrated that TTV may cause epidemic outbreak of hepatitis of unknown etiology by fecal-to-mouth way[6]. The high prevalence of active TTV infection (14.7%) in the general population was found in our study, suggesting that TTV, similar to HBV, may have “symptom-free carriers”. Further studies are urgently needed to determine the pathogenicity of TTV and the significance of “symptom-free carriers”.

We amplified and sequenced the ORF1 partial gene of TTV genome from 5 blood donors and compared these sequences with those of isolates from Japan and northern China. Our preliminary results showed that there are less than 2% nucleotide divergence among 5 isolates from blood donors. Compared with the isolates from Japan and northern China, the similarities of nucleotide sequences were above 97%. The data suggest that the ORF1 region of TTV genome is conserved in different geographic areas.

Footnotes

Edited by Ma JY

References
1.  Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun. 1997;241:92-97.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 856]  [Cited by in F6Publishing: 831]  [Article Influence: 30.8]  [Reference Citation Analysis (0)]
2.  Chen RG, Huang CH, Zhou YS, Wang HT. Detection of TTV infection in blood donors with elevated transamine levels of unknown etiology. Zhongguo Shuxue Zazhi. 1998;11:68-71.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H, Miyakawa Y, Mayumi M. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res. 1998;10:1-16.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 412]  [Cited by in F6Publishing: 309]  [Article Influence: 11.9]  [Reference Citation Analysis (0)]
4.  Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J, Yap PL, Ludlam CA, Haydon GH, Gillon J. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet. 1998;352:191-195.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 292]  [Cited by in F6Publishing: 279]  [Article Influence: 10.7]  [Reference Citation Analysis (0)]
5.  Meng Q, Zhou Y, Liu D. [Detection of TT virus infection and clinical investigation in patients with liver diseases]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 1998;12:111-114.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Lou KX, Zhang L, Wang SS, Nie J, Ge Y, Chen ZY. An outbreak of enteric transmitted non A, non-E viral hepatitis: primary study of clinical epidemiology andvirology. Zhonghua Ganzangbing Zazhi. 1998;6:161-163.  [PubMed]  [DOI]  [Cited in This Article: ]